Umeclidinium is prescribed for:
- COPD maintenance treatment
- Chronic bronchitis and emphysema
- Respiratory disease management
Works by blocking muscarinic receptors in airways.
Generic Name: Umeclidinium Bromide
Brand Names: Incruse Ellipta
Umeclidinium is a long-acting muscarinic antagonist (LAMA) for COPD maintenance treatment.
Umeclidinium is prescribed for:
Works by blocking muscarinic receptors in airways.
Common side effects:
Serious side effects:
Umeclidinium is a long-acting muscarinic antagonist (LAMA) providing 24-hour bronchodilation.
Blocks acetylcholine at muscarinic M3 receptors in airway smooth muscle, causing bronchodilation.
Available alone (Incruse) or combined with vilanterol (Anoro) or both vilanterol and fluticasone (Trelegy).
For details, see the prescribing information.
This medication is commonly used to treat or manage the following conditions:
Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.
Loading questions...
Have questions about Umeclidinium? Get expert answers from Dr. Zimmer.
Privacy: Your questions are posted anonymously for your health privacy. Your name and email are only used for admin purposes.
Questions are reviewed before posting. You'll see your question and Dr. Zimmer's answer below once approved.